|
"liu tw"的相關文件
顯示項目 71-120 / 139 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2015-12 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-11 |
Determinants of hospital death for Taiwanese pediatric cancer decedents, 2001–2010
|
Hung, YN;Liu, TW;Tang, ST |
| 國家衛生研究院 |
2015-08 |
Increasing receipt of high-tech/high-cost imaging and its determinants in the last month of Taiwanese patients with metastatic cancer, 2001-2010: A retrospective cohort study
|
Liu, TW;Hung, YN;Soong, TC;Tang, ST |
| 國家衛生研究院 |
2015-05 |
Preferences for aggressive end-of-life care and their determinants among Taiwanese terminally Ill cancer patients
|
Liu, LN;Chen, CH;Liu, TW;Lin, YC;Lee, SC;Tang, ST |
| 國家衛生研究院 |
2015-05 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-04 |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
Liang, PC;Ch'ang, HJ;Hsu, C;Chen, LT;Shih, TTF;Liu, TW |
| 國家衛生研究院 |
2015-04 |
Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C |
| 國立交通大學 |
2014-12-08T15:39:38Z |
Emission characteristics and control efficiency of acidic and basic gases and aerosols from packed towers
|
Tsai, CJ; Chang, CT; Liu, TW; Huang, CC; Chien, CL; Chein, HM |
| 國家衛生研究院 |
2014-12 |
Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study
|
Tang, ST;Liu, TW;Liu, LN;Chiu, CF;Hsieh, RK;Tsai, CM |
| 國家衛生研究院 |
2014-07 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2014-06 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL |
| 國家衛生研究院 |
2014-05 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study
|
Wang, LW;Hsiao, CF;Chen, WTL;Lee, HH;Lin, TC;Chen, HC;Chen, HH;Chien, CR;Lin, TY;Liu, TW |
| 臺北醫學大學 |
2014 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates amongTaiwanese terminally ill cancer patients surveyed in2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2012-10 |
Development and validation of an instrument for the measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective
|
Chang, HH;Chie, WC;Chin, YH;Hsu, CP;Liu, TW;Whang-Peng, J |
| 國家衛生研究院 |
2012-04 |
Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006
|
Liu, TW;Chang, WC;Wang, HM;Chen, JS;Koong, SL;Hsiao, SC;Tang, ST |
| 國家衛生研究院 |
2012-01 |
Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method
|
Chow, L;Lin, PC;Chang, JS;Chu, PY;Lee, PK;Chen, SN;Cheng, YM;Lee, JC;Chang, JY;Liu, TW |
| 國家衛生研究院 |
2012-01 |
Impact of age on end-of-life care for adult Taiwanese cancer decedents, 2001-2006
|
Tang, ST;Liu, TW;Shyu, YIL;Huang, EW;Koong, SL;Hsiao, SC |
| 國家衛生研究院 |
2011-12-15 |
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors
|
Kuo, CC;Liu, TW;Chen, LT;Shiah, HS;Wu, CM;Cheng, YT;Pan, WY;Liu, JF;Chen, KL;Yang, YN;Chen, SN;Chang, JY |
| 國家衛生研究院 |
2011-09 |
Impact of availability of an inpatient hospice unit on the Parent Hospital's quality of palliative care for Taiwanese cancer decedents, 2001-2006
|
Wang, HM;Koong, SL;Hsiao, SC;Chen, JS;Liu, TW;Tang, ST |
| 國家衛生研究院 |
2011-09 |
Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006
|
Tang, ST;Liu, TW;Chang, WC;Wang, HM;Chen, JS;Koong, SL;Hsiao, SC |
| 國家衛生研究院 |
2011-03 |
Pediatric end-of-life care for Taiwanese children who died as a result of cancer from 2001 through 2006
|
Tang, ST;Hung, YN;Liu, TW;Lin, DT;Chen, YC;Wu, SC;Hsu, TH |
| 國家衛生研究院 |
2011-01 |
Aggressive end-of-life care significantly influenced propensity for hospice enrollment within the last three days of life for Taiwanese cancer decedents
|
Tang, ST;Huang, EW;Liu, TW;Wang, HM;Rau, KM;Chen, JS |
| 高雄醫學大學 |
2011 |
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors.
|
陳立宗; Kuo CC;Liu TW;Chen LT;Shiah HS;Wu CM;Cheng YT;Pan WY;Liu JF;Chen KL;Yang YN;Chen SN;Chang JY. |
| 國家衛生研究院 |
2010-11 |
A population-based study on the determinants of hospice utilization in the last year of life for Taiwanese cancer decedents, 2001-2006
|
Tang, ST;Huang, EW;Liu, TW;Wang, HM;Chen, JS |
| 國家衛生研究院 |
2010-11 |
Determinants of ICU care in the last month of life for Taiwanese cancer decedents, 2001 to 2006
|
Wu, SC;Chen, JS;Wang, HM;Hung, YN;Liu, TW;Tang, ST |
| 國家衛生研究院 |
2010-10 |
Propensity for home death among Taiwanese cancer decedents in 2001-2006, determined by services received at end of life
|
Tang, ST;Huang, EW;Liu, TW;Rau, KM;Hung, YN;Wu, SC |
| 國家衛生研究院 |
2010-09 |
What really matters in pain management for terminally ill cancer patients in Taiwan
|
Tang, ST;Tang, WR;Liu, TW;Lin, CP;Chen, JS |
| 國家衛生研究院 |
2010-08 |
Determinants of patient-family caregiver congruence on preferred place of death in Taiwan
|
Tang, ST;Chen, CC;Tang, WR;Liu, TW |
| 國家衛生研究院 |
2010-07 |
Longer-term assessment of trastuzumab-related cardiac adverse events in the herceptin adjuvant (HERA) trial
|
Procter, M;Suter, TM;de Azambuja, E;Dafni, U;van Dooren, V;Muehlbauer, S;Climent, MA;Rechberger, E;Liu, TW;Toi, M;Coombes, RC;Dodwell, D;Pagani, O;Madrid, J;Hall, M;Chen, SC;Focan, C;Muschol, M;van Veldhuisen, DJ;Piccart-Gebhart, MJ |
| 國家衛生研究院 |
2010-03 |
Cancer care quality assessment in USA, UK and Taiwan
|
Liu, CM;Huang, KC;Chiu, CF;Liu, TW |
| 國家衛生研究院 |
2010-01-27 |
Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan
|
Chung, KP;Chang, YJ;Lai, MS;Kuo, RNC;Cheng, SH;Chen, LT;Tang, R;Liu, TW;Shieh, MJ |
| 國家衛生研究院 |
2009-12 |
A population-based study on the prevalence and determinants of cardiopulmonary resuscitation in the last month of life for Taiwanese cancer decedents, 2001-2006
|
Chen, JS;Wang, HM;Wu, SC;Liu, TW;Hung, YN;Tang, ST |
| 國家衛生研究院 |
2009-12 |
Quality of end-of-life care between medical oncologists and other physician specialists for Taiwanese cancer decedents, 2001-2006
|
Liu, TW;Chen, JS;Wang, HM;Wu, SC;Hung, YN;Tang, ST |
| 國家衛生研究院 |
2009-09 |
Determinants of Aggressive End-of-Life Care for Taiwanese Cancer Decedents, 2001 to 2006
|
Tang, ST;Wu, SC;Hung, YN;Chen, JS;Huang, EW;Liu, TW |
| 國家衛生研究院 |
2009-09 |
Performance of medical oncologists on end-of-life care for Taiwanese cancer decedents, 2001-2006
|
Tang, S;Liu, TW;Chen, JS;Wang, HM;Wu, SC;Hung, YN |
| 國家衛生研究院 |
2009-02 |
Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000-2006
|
Tang, ST;Wu, SC;Hung, YN;Huang, EW;Chen, JS;Liu, TW |
| 國立臺北護理健康大學 |
2009 |
Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000-2006
|
黃衍文; Tang, ST;Wu, SC;Hung, YN;Huang, EW;Chen, JS;Liu, TW |
| 國家衛生研究院 |
2008-12 |
Patient awareness of prognosis, patient-family caregiver congruence on the preferred place of death, and caregiving burden of families contribute to the quality of life for terminally ill cancer patients in Taiwan
|
Tang, ST;Liu, TW;Tsai, CM;Wang, CH;Chang, GC;Liu, LN |
| 國家衛生研究院 |
2008-12 |
Medical resource utilizations and economic burden in Chinese cancer patients with chemotherapy-induced anemia: A populational database study
|
Liu, CY;Liu, TW;Liu, JS;Hsiao, CF;Chen, LT |
| 國家衛生研究院 |
2008-03 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Chao, TY; Liu, TW; Cheng, AL; Chen, PJ |
| 國立臺灣大學 |
2008-03 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial.
|
Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ |
| 國家衛生研究院 |
2007-05 |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result
|
Liang, PC; Ch'ang, HJ; Hsu, C; Tseng, SS; Shih, TTF; Liu, TW |
| 國家衛生研究院 |
2007 |
A prospective comparative study of prophylactic or therapeutic use of lamivudine for chemotherapy-associated hepatitis B (HBV) reactivation in nowhodgkin's lymphoma (NHL) patients
|
Hsu, C;Hsiung, CA;Su, LJ;Hwang, WS;Wang, MC;Lin, SF;Lin, TH;Hsiao, HH;Young, JH;Chang, MC;Huang, MJ;Liao, YM;Li, CC;Wu, HB;Chao, TY;Liu, TW;Cheng, AL;Chen, PJ |
| 國家衛生研究院 |
2006-11 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah, HS; Chao, Y; Chen, LT; Yao, TJ; Huang, JD; Chang, JY; Chen, PJ; Chuang, TR; Chin, YH; Whang-Peng, J; Liu, TW |
| 國家衛生研究院 |
2006-07 |
Congruence of knowledge, experiences, and preferences for disclosure of diagnosis and prognosis between terminally-ill cancer patients and their family caregivers in Taiwan
|
Tang, ST; Liu, TW; Lai, MS; Liu, LN; Chen, CH; Koong, SL |
| 國立臺灣大學 |
2006-06 |
Controlled growth of aluminium nitride nanorod arrays via chemical vapour deposition
|
Yang J; Liu TW; Hsu CW; Chen LC; Chen KH; Chen CC |
| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-03 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-01 |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma
|
Wang, CC; Chang, JY; Liu, TW; Lin, CY; Yu, YC; Hong, RL |
| 國家衛生研究院 |
2005-12 |
Pulmonary embolism after transcatheter arterial chemoembolization
|
Shiah, HS; Liu, TW; Chen, LT; Chang, JY; Liu, JM; Chuang, TR; Lee, WS; Whang-Peng, J |
顯示項目 71-120 / 139 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
